Brussels, 01/03/2012 (Agence Europe) - On 1 March, the European Commission proposed provisions to revise the 1989 Transparency Directive on pharmaceutical products, so that patients obtain faster access to medicines. The new directive represents an important simplification measure and repeals and replaces the earlier directive, which no longer reflected the increased complexity of pricing and reimbursement procedures in member states. The European Commission intends to streamline and reduce...